Navigation Links
ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium

NEW YORK, July 28, 2014 /PRNewswire/ -- David Hardison, Ph.D., vice president of health services for ConvergeHEALTH by Deloitte, has been elected chairman of the board for the Clinical Data Interchange Standards Consortium, a non-profit working to establish common protocols around the use of clinical research data, particularly as it relates to electronic health records.

Hardison will work to continue CDISC's mission of collaborating with organizations across the research and health care arena in harmonizing practices related to the acquisition, exchange, submission and archiving of clinical data and metadata.  He previously served as CDISC's chairman from 2005 to 2007.

"We are pleased to have David chair the organization once again and bring his expertise in the field to our organization," said Dr. Rebecca Kush, president and chief executive officer of CDISC. "CDISC appreciates that ConvergeHEALTH supports the open-source development of data standards and innovation to improve medical research and interoperability in many areas of health care."

Hardison said his appointment reflects Deloitte's commitment to the importance of standards-based innovation in health care.  "I have been a champion of CDISC for many years and look forward to my continued support of the organization and its vision to 'inform patient care and safety through higher quality medical research.'"

Hardison has more than 30 years of experience in the biopharmaceutical and providers sectors, including executive and board-level roles related to information technology and performance improvement. 

Hardison will speak at the CDISC Asia-Pacific/Japan Interchange 2014 on July 31 in Tokyo, an event that runs from July 28 through Aug. 1.

CDISC is a 501(c)(3) global non-profit charitable organization with more than 300 supporting member organizations from across the clinical research and health care arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can significantly decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning health care system. The CDISC vision is to inform patient care and safety through higher quality medical research. For more information, visit

About ConvergeHEALTH by Deloitte
ConvergeHEALTH brings powerful, demonstrated analytics platforms and data models from Recombinant by Deloitte, advanced proprietary and open-source analytics, content and benchmarks through collaboration with industry leaders and deep experiences from Deloitte's Life Sciences and Health Care consulting practice to help our clients survive and thrive in the new paradigm of value-based, personalized medicine.  For more information, visit

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP.  Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Logo -  

SOURCE Deloitte
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer
2. DuPont Congratulates David Hula for Breaking Corn Yield World Record with Pioneer® Brand Hybrid P2088YHR in 2013 NCGA Corn Yield Contest
3. Barnet Dulaney Perkins Eye Center Regrets to Announce the Passing of David Dulaney, MD
4. Atlas Appoints David Whitaker as Operations Director
5. Dr. David R. Bassett Joins ActiGraph Scientific Advisory Board
6. David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research
7. David Hooper Joins Evolution Marketing Research as Senior Director, Research
8. Can Science Really Get You Laid? The Shocking Truth About Dr. David Tan's "Desire System"
9. Dr. David Slaughter Launches Groundbreaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
11. David Smith Named Vice President of Operations for HealthTell
Post Your Comments:
(Date:10/8/2015)... 8, 2015  Today the Wyss Institute for Biologically ... its start-up company Opsonix Inc. The announcement ... Office of Technology Development (OTD) and Opsonix Inc. ... for clinical use. --> ... million people every year in the U.S. — more ...
(Date:10/8/2015)... ... 2015 , ... Talon Innovations, a provider of Precision Machined Products ... it is one of three finalists for the Minnesota Business magazine’s Manufacturing Award in ... Talon Innovations was recognized as a nominee for this competitive award. , The ...
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic ... transmembrane conductance regulator (CFTR) gene and results in dysfunction of the lungs and ... in the lungs. This mucus is very difficult to clear, blocks the airways ...
(Date:10/7/2015)... Boston Scientific (NYSE: BSX ... Boston Scientific Connected Patient Challenge , an open innovation ... remote patient monitoring to enhance patient care.  Until January ... their ideas and collaborate on solutions through Medstro,s ... Cambridge, MA where they will present ...
Breaking Biology Technology:
... international team of scientists has determined the structure of the ... light energy. The team,s results one day could be ... convert solar energy to electrical energy. A research paper ... in the Proceedings of the National Academy of Sciences ...
... Sales Force Reduction and Approximately $45 Million Annual GAAP ... Inc. (Nasdaq: AMLN ) today announced a ... existing primary care and specialty sales forces will merge ... to endocrinologists and diabetes-focused primary care physicians. The changes ...
... The Arcas Group, a leading life-sciences marketing organization, ... Executive Vice President. He will assume responsibility for the ... President of Imedex, Inc."Stefan is an experienced executive who ... company," said Founder and President Jan Heybroek. "I ...
Cached Biology Technology:
(Date:9/30/2015)... -- The global glucose monitoring device and diabetes management market is ... report on the industry from Kalorama Information. Sales in the traditional ... by continuous glucose monitoring and sensor segment, according to the ... products in its latest report, The Global Glucose Monitoring ... , ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of ... will be unveiled today at the Stanford Medicine ... Engagement Using iPad Dashboards, Connected Health Devices and ... of Pharmacy 3.0, will explain how senior patients ... data to their pharmacist via the TactioRPM remote ...
Breaking Biology News(10 mins):
... to restore vision through the use of a component ... University professor and scientific director of the Ligon Research ... has attracted additional funding for therapy development. The ... affiliate, National Neurovision Research Institute, to RetroSense Therapeutics, LLC, ...
... miniaturized lizards have been identified in Madagascar. These lizards, just tens ... enough to stand on the head of a match, rank among ... found in the Feb. 15 issue of the open access journal ... of the Zoological State Collection of Munich in Germany, also conducted ...
... Invasive species which have the potential to destroy biodiversity ... in the same way as wanted criminals, according to ... Geographic profiling (GP) was originally developed as a statistical ... linked crimes (for example murder, rape or arson) to ...
Cached Biology News:
PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....
Mouse Iduronate 2-Sulfatase Affinity Purified Polyclonal Ab Keywords: Sulfatases, Iduronate 2-Sulfatase, Mucopolysaccharidosis, Hunter Syndrome, Glycobiology Protein Family: Proteoglycan Regu...
An instrument that delivers an accurate and uniform amount of light energy to cells to photoactivate csiRNA products....
interferon-related developmental regulator 2...
Biology Products: